...
首页> 外文期刊>Recent patents on anti-cancer drug discovery >Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase
【24h】

Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase

机译:通过对接和限制羟基核糖核酸还原酶作用的分子动力学模拟对羟基脲进行建模并提出分子机理

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Ribonucleotide Reductase (RNR) is an important anticancer chemotherapy target. It has main key role in DNA synthesis and cell growth. Therefore several RNR inhibitors, such as hydroxyurea, have entered the clinical trials. Based on our proposed mechanism, radical site of RNR protein reacts with hydroxyurea in which hydroxyurea is converted into its oxidized form compound III, and whereby the tyrosyl radical is converted into a normal tyrosine residue.
机译:背景:核糖核苷酸还原酶(RNR)是重要的抗癌化疗靶标。它在DNA合成和细胞生长中起主要关键作用。因此,几种RNR抑制剂,例如羟基脲,已进入临床试验。基于我们提出的机理,RNR蛋白的自由基位点与羟基脲反应,其中羟基脲被转化为其氧化形式的化合物III,从而酪氨酰基被转化为正常的酪氨酸残基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号